CELLULAR RESISTANCE TO THE ANTIRETROVIRAL DRUGS

CELLULAR RESISTANCE TO THE ANTIRETROVIRAL DRUGS

-

Bibliographic Details
Main Author:	G. Antonelli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2004-06-01
Series:	Microbiologia Medica
Online Access:	http://www.pagepressjournals.org/index.php/mm/article/view/3723

Similar Items

Epidemiology and Evolution of Antiretroviral Drug Resistance
by: Wainberg Mark A
Published: (2005-12-01)

The Russian database of HIV antiretroviral drug resistance
by: Dmitry E. Kireev, et al.
Published: (2023-05-01)

Antiretroviral Drug Resistance and Routine Therapy, Cameroon
by: Christian Laurent, et al.
Published: (2006-06-01)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
by: Charlotte Charpentier, et al.
Published: (2023-02-01)

Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages
by: Stefano Aquaro, et al.
Published: (2020-12-01)

Current Perspectives on HIV-1 Antiretroviral Drug Resistance
by: Pinar Iyidogan, et al.
Published: (2014-10-01)

Combined antiretroviral and antituberculosis drug resistance following incarceration
by: Katharine Elizabeth Stott, et al.
Published: (2013-09-01)

Analysis of the frequency of formation of HIV mutations associated with resistance to antiretroviral drugs
by: M.G. Liulchuk, et al.
Published: (2020-09-01)

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
by: Pontiano Kaleebu, et al.
Published: (2015-01-01)

Update on the Prevalence of Antiretroviral Drug Resistance in Treatment-Naive Individuals
by: Christopher W. James PharmD, et al.
Published: (2013-05-01)

Cellular proteins as potential targets for antiretroviral therapy
by: Marina R. Bobkova
Published: (2023-12-01)

Five Antiretroviral Drug Class–Resistant HIV-1 in a Treatment-Naïve Patient Successfully Suppressed with Optimized Antiretroviral Drug Selection
by: Joseph M. Volpe PhD, et al.
Published: (2015-09-01)

Pharmacogenetics of antiretroviral drugs
by: Dragović Gordana, et al.
Published: (2012-01-01)

Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations.
by: Susana Monge, et al.
Published: (2014-01-01)

Evaluating a minipool strategy to screen for virologic failure and antiretroviral drug resistance
by: H.M. Newman, et al.
Published: (2014-04-01)

HIV Antiretroviral Drug Resistance: What's new in Mali? What is the future?
by: Almoustapha Maiga, et al.
Published: (2016-02-01)

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania
by: Holberg-Petersen Mona, et al.
Published: (2009-07-01)

Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy.
by: Andrea L Martinez-Skinner, et al.
Published: (2015-01-01)

Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic.
by: Wendy Grant-McAuley, et al.
Published: (2020-01-01)

Pharmacokinetics of antiretroviral drugs in infancy
by: Helen McIlleron, et al.
Published: (2009-12-01)

HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam.
by: Thao, V, et al.
Published: (2012)

Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy
by: Globahan Ajibola, et al.
Published: (2020-01-01)

The end of the line? A case of drug resistance to third-line antiretroviral therapy
by: Theresa M. Rossouw, et al.
Published: (2016-05-01)

Pretreatment HIV drug resistance in adults initiating antiretroviral therapy in China, 2017
by: Rui-Hua Kang, et al.
Published: (2020-05-01)

Disrupting cellular memory to overcome drug resistance
by: Guillaume Harmange, et al.
Published: (2023-11-01)

Enzalutamide and antiretroviral drugs: a challenge for clinicians
by: G. Gardini, et al.
Published: (2021-09-01)

Drug–drug interaction analysis: Antituberculosis drugs versus antiretroviral drugs
by: Won Sriwijitalai, et al.
Published: (2019-01-01)

Advances in the transdermal delivery of antiretroviral drugs
by: Liknaw Workie Limenh
Published: (2024-01-01)

Injectable Antiretroviral Drugs: Back to the Future
by: Marco Berruti, et al.
Published: (2021-02-01)

Nanodelivery of antiretroviral drugs to nervous tissues
by: Sodiq Kolawole Lawal, et al.
Published: (2022-11-01)

Chemical and Toxicological Analysis of Antiretroviral Drugs
by: T. N. Komarov, et al.
Published: (2019-11-01)

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.
by: Inzaule, S, et al.
Published: (2016)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
by: Castro Hannah, et al.
Published: (2012-03-01)

The Prevalence and Related Effects of HIV Drug-Resistant Strains Against Antiretroviral Therapy in China
by: Hui Xing, et al.
Published: (2022-06-01)

Antiretroviral drug resistance among U.S. veterans living with human immunodeficiency virus 1
by: Rahul Mahapatra, et al.
Published: (2019-03-01)

HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients.
by: Hui Xing, et al.
Published: (2013-01-01)

Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.
by: Irene Bontell, et al.
Published: (2013-01-01)

HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy.
by: Santiago Avila-Ríos, et al.
Published: (2015-01-01)

Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death
by: David Vlahov, et al.

Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa
by: Lise Jamieson, et al.
Published: (2019-12-01)